Châu Âu cấp phép lưu hành cho vắcxin COVID-19 của Pfizer-BioNTech

Theo THX 08:18 22/12/2020

Ngày 21/12, Cơ quan Quản lý Dược phẩm châu Âu (EMA) đã chính thức cấp phép lưu hành cho vắcxin ngừa bệnh COVID-19 do hai công ty Pfizer (Mỹ) và BioNTech (Đức) phối hợp nghiên cứu và sản xuất.

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